round tables held
Health Innovation Netherlands (HI-NL) aims at evaluating, implementing, and upscaling impactful innovations that match societal needs in order to help design a sustainable healthcare system – using fit-for-purpose evaluation processes:
- Earlier. Engaging at an early stage all important stakeholders involved in the use, evaluation, decision-making, implementation, reimbursement, and upscaling of innovations
- Faster. Ensuring a more rapid process via customization and proven ‘fit-for-innovation’ guidance
- More effective. Ultimately, we hope to contribute to the improved implementation of promising innovations, and termination or substitution of non-promising innovations.
HI-NL aims to become a leading public-private partnership, the go-to partner in the Netherlands, and a portal towards the rest of Europe and North America, whenever support is required for the evaluation and implementation of medical innovations.
HI-NL also aims to create a joint research agenda, which prioritizes the activities that can best improve healthcare and the innovation process. Much will also change when the new European regulation (MDR) takes effect in May 2020. This requires us to respond, but also provides us with a valuable opportunity to improve the current evaluation and decision-making process around non-pharmaceutical innovations.
HI-NL is supported by the Dutch Ministry of Health and is fully aligned with its mission on Health and Care.
Lygature together with
Health Innovation Netherlands officially launched: Infrastructure to faster deliver better medical devices
Health Innovation Netherlands was officially launched during the "Werkconferentie Nationale Medtech Agenda 2020-2025" at the Dutch Ministry of Health.
Health Innovation Netherlands (HI-NL) provides a multi-stakeholder infrastructure where patients, doctors, health care-providers, methodologists, CE-experts, entrepreneurs, insurers, investors, and regulatory authorities can all contribute to the faster delivery of better medical devices.